1. gmucaria
2. tfeh1389
3. kotommi7947
4. gary452849
5. lukeadlard
1.gmucaria 03/12/2018
Regeneron and Sanofi Announce Praluent Met Primary Endpoint of Reducing Cardiovascular Events
2.gary452849 01/23/2018
Cut to underweight, fun
3.tfeh1389 01/29/2018
Take it to the bank news :) - Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion). Company is payi…
4.kotommi7947 05/01/2018
Sanofi and Regeneron to lower net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients
5.lukeadlard 04/27/2018
Sanofi: First-quarter 2018 Business EPS(1) up 1.4% at CER
6.gary452849 02/05/2018
Two emerging market drug companies
7.lukeadlard 04/25/2018
FDA accepts for review Supplemental Biologics License Application for 0.5 mL dose of Fluzone® Quadrivalent (Influenza Vaccine) in children 6-35 months of age
8.gary452849 04/03/2018
Regeneron Pharmaceuticals and Sanofi announced that the European Medicines Agency has accepted for review the…
9.kotommi7947 05/03/2018
Sanofi: Annual General Shareholders' Meeting of May 2, 2018
10.tfeh1389 02/07/2018
LMAO. how did they miss?
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW